Lake Street Advisors Group »

Cartesian Therapeutics shares owned by Lake Street Advisors Group

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Lake Street Advisors Group from 13F filings

Historical chart of Lake Street Advisors Group investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Lake Street Advisors Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Lake Street Advisors Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $855k 32k 27.01

More positions owned by Lake Street Advisors Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Rus 1000 Etf (IWB)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Apple (AAPL)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Lake Street Advisors Group

Top funds holding Cartesian Therapeutics

BlackRock
Jpmorgan Chase & Co
Artal Group
MPM Oncology Impact Management
Ikarian Capital
Vanguard Group
State Street Corporation
Geode Capital Management
Logos Global Management
Nuveen Asset Management
Lake Street Advisors Group
Marshall Wace
Sphera Funds Management
Delphi Financial
Bank of New York Mellon

View all funds holding Cartesian Therapeutics